Stockhouse.com uses cookies on this site. By continuing to use our service, you agree to our use of cookies. Cookies are used to offer you a better browsing experience and to analyze our traffic. We also use them to share usage information with our partners. See full details.
I Agree
×
Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Privacy Policy | Disclaimer

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Privacy Policy | Disclaimer
Please Try Again {{ error }}

Send my password

Return to Login
SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
News Focus
LNG Energy Announces Signing of Hydrocarbon Productive Participation Contracts (click to learn more)
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Stock Quote Today & Recent News InMed Pharmaceuticals Inc INM

Healthcare Cannabis
InMed Pharmaceuticals Inc. is a clinical-stage pharmaceutical company. The Company is engaged in developing a pipeline of prescription-based products, including rare cannabinoids and cannabinoid analogs, targeting the treatment of diseases with high unmet medical needs, as well as developing proprietary manufacturing technologies to produce rare cannabinoids for sale in the health and wellness... see more
{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
{{currentVideo.headline}}
{{currentVideo.link1Text}}
{{currentVideo.link2Text}}
< Previous
{{moreVideoText}}
Next >

Current News (NDAQ:INM)

InMed Appoints Dr. David G. Morgan, PhD, a Leading Alzheimer's Expert, to the Company's Scientific Advisory Board

Newsfile 6 days ago

InMed Provides Update on INM-089 in the Treatment of Dry Age-Related Macular Degeneration

Newsfile 8 days ago

InMed's INM-901 Demonstrates Favorable Pharmacological and Behavioral Effects in In Vivo Preclinical Alzheimer's Disease Studies

Newsfile April 4, 2024

InMed Granted 180-Day Extension to Achieve Nasdaq Minimum Bid Compliance

Newsfile March 20, 2024

InMed Reports Second Fiscal Quarter 2024 Financial Results and Provides Business Update

Newsfile February 13, 2024

InMed Pharmaceuticals Strengthens Executive Leadership Team with Appointment of Ms. Netta Jagpal as Chief Financial Officer

Newsfile February 9, 2024

InMed to Discuss Its Pharmaceutical Pipeline and 2024 Strategic Priorities in Fireside Chat with Water Tower Research on January 25, 2024 at 1pm ET

Newsfile January 18, 2024

InMed Pharmaceuticals Provides Business Update and Milestones for 2024

Newsfile January 16, 2024

InMed Announces Results of 2023 Annual General Meeting

Newsfile December 19, 2023
View More News ››

Opinion & Analysis (NDAQ:INM)

InMed Shares Trade Up 25% After Becoming First to Advance Cannabinol into Clinical Trials

Streetwise Reports January 21, 2020

The 2019 Benzinga Cannabis Capital Conference: Everything You Missed In Miami Beach

Hannah Genig April 1, 2019

Cannabis Technologies (C.CAN) lays out clear path to creating shareholder value

Stockhouse Editorial June 23, 2014
View More Opinion ››

Bullboard Posts (NDAQ:INM)

Positive In Vivo Preclinical Alzheimer’s results

https://mailchi.mp/02da2462c4f8/inmeds-inm-901-demonstrates-favorable-pharmacological-and-behavioral-effects-in-in-vivo-preclinical...
zardoz00 - April 4, 2024

Good update on Inmed

https://wallstreetwaves.com/inmed-pharmaceuticals-has-multiple-milestones-coming-up-in-2024-with-a-focus-on-three-conditions-with-an...
zardoz00 - January 25, 2024

INM revenues have been exploding

https://mailchi.mp/550c403a5512/inmed-provides-update-on-baymedica-rare-cannabinoid-business?e=5815d309bc
zardoz00 - July 27, 2023

Minor Cannabinoid Sales - Ray of Hope

https://youtu.be/lTC25Wcj04I
Bullknit101 - June 11, 2023

INM Q3 report

https://mailchi.mp/d9827ae25b92/inmed-reports-second-quarter-fiscal-2023-financial-results-and-provides-business-update-13895526?e...
zardoz00 - May 15, 2023

INM publishes peer reviewed study

https://mailchi.mp/dc7a414475c6/inmed-announces-publication-of-peer-reviewed-study-showing-the-anti-inflammatory-potential-of-rare...
zardoz00 - March 13, 2023
View more Bullboard ››

Tenet Fintech Group Inc.

Tenet Fintech Group Inc.

Tenet Fintech Group Inc. is the parent company of a group of innovative financial technology (Fintech) and artificial ...
View More »